Page last updated: 2024-11-13

fertinex

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID75409771
CHEMBL ID3276116
CHEMBL ID3249216
MeSH IDM0475588

Synonyms (9)

Synonym
urofollitrophin
fertinorm hp
orgafol
urofollitropin [usan:inn:ban]
fertinex
metrodin
bravelle
CHEMBL3276116
CHEMBL3249216
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID1150413Activity at oxytocin receptor in rat uterus1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1150419Antidiuretic activity in rat1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1150418Vasopressor activity in rat1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1150422Activity at oxytocin receptor in rat uterus relative to oxytocin1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1150421Ratio of activity at oxytocin receptor in rat uterus to antidiuretic activity in rat1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1150414Activity at oxytocin receptor in rat uterus in presence of 0.5 mM Mg2+1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1150420Ratio of activity at oxytocin receptor in rat uterus to vasopressor activity in rat1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1150417Oxytocic activity in rabbit assessed as milk ejection1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-
AID1133493Ratio of oxytocic potency to antidiuretic activity in rat1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic
AID1133926Oxytocic potency in rat uterus1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
AID1150126Oxytocic potency in rat uterus in presence of 0.5 mM Mg2+1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID1150128Antidiuretic activity in iv dosed hydrated rat anesthetized with ethanol1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
AID1133927Vasodepressor activity in conscious chicken1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
AID1133491Antidiuretic activity in iv dosed rat1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic
AID1150130Ratio of oxytocic potency in rat uterus to antidiuretic activity in iv dosed hydrated rat anesthetized with ethanol1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
AID1150131Ratio of oxytocic potency in rat uterus to vasopressor activity in phenoxybenzamine-treated rat under urethane anesthesia1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
AID1133487Oxytocic potency in rat by uterus assay1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic
AID1150125Oxytocic potency in rat uterus1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
AID1150129Vasopressor activity in phenoxybenzamine-treated rat under urethane anesthesia1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
AID1133492Vasopressor activity in rat1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic
AID1133490Oxytocic potency in rat assessed as milk ejection1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic
AID1133928Antidiuretic activity in iv dosed rat1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
AID1133930Vasopressor activity in rat1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
AID1133929Ratio of oxytocic potency to antidiuretic activity in rat1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
AID1150127Oxytocic activity in iv dosed lactating rat anesthetized with pentobarbital assessed as milk ejection1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
AID1133488Oxytocic potency in rat by uterus assay in presence of 0.5 mM Mg2+1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.79 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index49.93 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]